Terkko Navigator / Harvima, I.

Sequential Increase in Complement Factor I, iC3b, and Cells Expressing CD11b or CD14 in Cutaneous Vasculitis

Survival from cutaneous malignant melanoma is improving, but is it because of a trend in decreasing melanoma thickness or the advent of new 'revolutionary' therapeutics?

Case: Unexpected development of severe penicillin allergy and review of literature

High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types

Association of Elevated Serum Tryptase with Cutaneous Photodamage and Skin Cancers

Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1

Mast Cells and Sensory Nerves Contribute to Neurogenic Inflammation and Pruritus in Chronic Skin Inflammation

Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin Carcinomas

Mast cell chymase degrades fibrinogen and fibrin

Increase in FoxP3-positive Cells and Their Contacts with Mast Cells in Köbner-negative Patients with Psoriasis after Tape-stripping

Mast cell-neural interactions contribute to pain and itch

Accuracy and reliability of a hand-held in vivo skin indentation device to assess skin elasticity

Immunoreactivity to CYP24A1, but not vitamin D receptor, is increased in mast cells of keratinocyte skin cancers

CD40 Ligand Is Increased in Mast Cells in Psoriasis and Actinic Keratosis but Less So in Epithelial Skin Carcinomas

Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase

Immediate Wheal Reactivity to Autologous Sweat in Atopic Dermatitis Is Associated with Clinical Severity, Serum Total and Specific IgE and Sweat Tryptase Activity

Increased mitogen-stimulated lymphocyte proliferation is associated with the clinical response in major depressive disorder in women: A follow-up study

Mast cell chymase in experimentally induced psoriasis

Epidermal Expression of Filaggrin/Profilaggrin Is Decreased in Atopic Dermatitis: Reverse Association With Mast Cell Tryptase and IL-6 but Not With Clinical Severity

Mast cell tryptase and chymase in the progress of cutaneous vasculitis

Mast cells express CYP27A1 and CYP27B1 in epithelial skin cancers and psoriasis

Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma

Experimentally induced psoriatic lesions associate with rapid but transient decrease in interleukin-33 immunostaining in epidermis

Increased numbers of tryptase-positive mast cells in the healthy and sun-protected skin of tobacco smokers

Decrease in chymase activity is associated with increase in IL-6 expression in mast cells in atopic dermatitis

Molecular targets on mast cells and basophils for novel therapies

Reduced serum adiponectin levels in alexithymia

Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor

Glucocorticoids and aetiopathogenesis of depression

Anti-apoptotic BFL-1 is the major effector in activation-induced human mast cell survival

OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity

Stress, the neuroendocrine system and mast cells: current understanding of their role in psoriasis

Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder

Mast cells as regulators of skin inflammation and immunity

Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro

The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics

Role of mast cells and sensory nerves in skin inflammation

Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation

Human mast cells adhere to and migrate on epithelial and vascular basement membrane laminins LM-332 and LM-511 via alpha3beta1 integrin

Induction of matrix metalloproteinase-9 in keratinocytes by histamine

Is there a role for mast cells in psoriasis?

Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysis

Expression of 15-lipoxygenase type-1 in human mast cells

The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma

Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency

Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma

Histamine, but not leukotriene C4, is an essential mediator in cold urticaria wheals

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion

Hyaluronic acid inhibits the adherence and growth of monolayer keratinocytes but does not affect the growth of keratinocyte epithelium

How should the care of dermatological diseases be developed?